Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1205847746

Golden State Eye Medical Group INC

Golden State Eye Medical Group INC was paid $11.19M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 40% of everything it billed.

33Billing provider infoGOLDEN STATE EYE MEDICAL GROUP INC
BAKERSFIELD, CA 93301
33aNPI1205847746assigned 08/10/2006
33bProvider typeOptician
28Total paid$11.19M
24GClaims81,242
24DCodes billed29
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Optician providers in California

Rank by total paid#1 of 24
Median peer was paid$17K
This provider vs. median649×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20189,616$487K
201912,490$732K
202012,753$865K
202111,342$1.55M
202210,950$3.24M
202310,355$1.99M
2024incomplete13,736$2.32M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J0178 Injection, aflibercept, 1 mg 40% 4,787 2,731 $4.44M
67028 Intravitreal injection of a pharmacologic agent 22% 9,594 5,713 $2.46M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 17% 13,925 12,731 $1.89M
92134 5.1% 12,856 11,555 $574K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 3.2% 3,558 3,516 $356K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.2% 2,982 2,829 $250K
92226 1.9% 5,535 2,639 $213K
76512 1.9% 4,739 2,737 $209K
J9035 Injection, bevacizumab, 10 mg 1.4% 2,752 2,113 $159K
92225 1.1% 2,439 1,215 $124K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 1,191 1,186 $98K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 1,557 1,551 $91K
17 more codes
92201 <1% 4,009 $83K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 1,087 $52K
92015 Determination of refractive state <1% 4,938 $49K
92202 <1% 2,702 $33K
67210 <1% 53 $25K
92133 <1% 817 $24K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 236 $14K
V2020 Frames, purchases <1% 546 $12K
92340 Fitting of spectacles, except for aphakia; monofocal <1% 412 $9K
J7999 Compounded drug, not otherwise classified <1% 284 $7K
67228 <1% 16 $5K
92060 <1% 147 $3K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 12 $2K
67515 <1% 20 $1K
92083 <1% 13 $494.87
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 18 $88.05
92310 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTAWANSY, KHALED (OWNER)
Same official

Other billing entities under TAWANSY, KHALED

Full network →
ProviderLocationPaid
Khaled A. Tawansy, M.D., INCLos Angeles, CA$3.95M
Raymond Renaissance Surgery Center LLCPasadena, CA$197K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.